At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia: a Randomized Controlled Trial
In Brief
A clinical study evaluating Valsalva assist device and standard Valsalva manoeuvre for Supraventricular Tachycardia (SVT). Completed, enrolled 212 participants across 1 site.
Detailed Summary
The goal of this clinical trial is to evaluate the efficiency of a device for terminating supraventricular tachycardia. The main questions it aims to answer are: The Valsalva manoeuvre is a first-line treatment for supraventricular tachycardia, but the success rate is low. Can the device help to increase the sucess rate? Whether the device is effective and safe to use at home? Researchers will compare whether the device is more effective than a standard Valsalva manoeuvre to treat supraventricular tachycardia. Participants will: be randomly assigned (1:1) to a standard Valsalva manoeuvre group (control) or Valsalva manoeuvre with the device (intervention) .
Study Details
Timeline
Interventions
A valsalva assist device designed to provide the recommended resistance to exhalation at a pressure of 40 mmHg.
The Valsalva manoeuvre is carried out without any device.